Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 2
2020 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, Moll AC, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab and Ranibizumab in Diabetic Macular Edema Study Group. Vader MJC, et al. Among authors: schauwvlieghe ame. Ophthalmol Retina. 2020 Aug;4(8):777-788. doi: 10.1016/j.oret.2020.02.008. Epub 2020 Feb 27. Ophthalmol Retina. 2020. PMID: 32362552 Free article. Clinical Trial.
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial.
Vader MJC, Schauwvlieghe AME, Verbraak FD, Dijkman G, Hooymans JMM, Los LI, Zwinderman AH, Peto T, Hoyng CB, van Leeuwen R, Vingerling JR, de Jong-Hesse Y, van Lith-Verhoeven JJC, Dijkgraaf MGW, Schlingemann RO; Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) Study Group. Vader MJC, et al. Among authors: schauwvlieghe ame. Ophthalmol Retina. 2020 Jun;4(6):576-587. doi: 10.1016/j.oret.2019.12.019. Epub 2020 Jan 7. Ophthalmol Retina. 2020. PMID: 32107188 Free article. Clinical Trial.
Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial.
Buitendijk GHS, Schauwvlieghe AME, Vingerling JR, Schlingemann RO, Klaver CCW; comparing Bevacizumab to Ranibizumab in Age-related macular degeneration (BRAMD) Trial Research Group. Buitendijk GHS, et al. Among authors: schauwvlieghe ame. Am J Ophthalmol. 2018 Mar;187:130-137. doi: 10.1016/j.ajo.2018.01.003. Epub 2018 Jan 9. Am J Ophthalmol. 2018. PMID: 29330064 Clinical Trial.